Grade: F — Major Red Flags
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Filed 2026-02-03, FY ended December 31, 2025) + Yahoo Finance
Auditor: Deloitte & Touche LLP — Unqualified opinion
One-line verdict: Dow reported a net loss of $2.6 billion in FY2025, including a $690 million goodwill impairment in its Polyurethanes & Construction Chemicals unit and a $303 million asset impairment in Latin American operations. Four screening checks fail: AR outpacing revenue for two years, cash covering only 19% of $19.6B debt, goodwill at 59% of equity, and Debt/EBITDA exploding to 16.5x with interest coverage collapsing to 0.2x. Gross margin cratered from 10.7% to 6.3% as commodity chemicals pricing deteriorated. The Z-Score of 2.15 sits in the grey zone. Despite passing the M-Score at -2.41, Dow's financial position deteriorated severely in FY2025 across nearly every metric.
| Metric | Result |
|---|---|
| Red Flags | **4** (AR trend, cash-to-debt, goodwill/equity, leverage) |
| Watch Items | **3** (CFFO/NI, negative FCF, FCF after acquisitions) |
| Checks Completed | **18/18** |
| Beneish M-Score | **-2.41** (passes) |
| Z-Score | **2.15** (grey zone) |
| Auditor | Deloitte & Touche LLP — serving since 1905 |
Three Segments, All Under Pressure
Per the filing, Dow operates three segments:
| Segment | FY2025 Net Sales | FY2024 Net Sales | Description |
|---|---|---|---|
| Packaging & Specialty Plastics | ~$20.6B | ~$21.9B | Polyolefins, hydrocarbons |
| Industrial Intermediates & Infrastructure | ~$12.1B | ~$13.2B | Polyurethanes, industrial solutions |
| Performance Materials & Coatings | ~$7.3B | ~$7.9B | Coatings, silicones |
Revenue declined from $43.0B to $40.0B (-7.0%). The filing states: "Net income (loss) available for Dow Inc. was a loss of $2,623 million in 2025, compared with income of $1,116 million in 2024."
The $690 million goodwill impairment was recorded when "the Company determined the fair value of the Polyurethanes & Construction Chemicals reporting unit was lower than its carrying amount." An additional $303 million impairment was "related to assets used for chlor-alkali, propylene oxide and brine production in Latin America due to challenging economic conditions in the region."
Profitability: Cyclical Collapse
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|---|
| Revenue | $56,902M | $44,622M | $42,964M | $39,968M | -30% from peak |
| Net Income | $4,582M | $589M | $1,116M | -$2,623M | Collapsed |
| Gross Margin | 15.1% | 10.9% | 10.7% | 6.3% | Severe deterioration |
| EPS (diluted) | $6.47 | $0.84 | $1.58 | -$3.70 | Loss year |
Revenue has declined 30% from the 2022 peak of $56.9B. Gross margin of 6.3% is dangerously thin for a capital-intensive chemicals company. Interest expense rose to $865 million, up from $811 million, driven by "$1.4 billion" in new long-term debt.
Cash Flow: Deteriorating Sharply
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating Cash Flow | $5,196M | $2,914M | $1,032M |
| Net Income | $589M | $1,116M | -$2,623M |
| CFFO / NI | 8.82 | 2.61 | -0.39 |
| CapEx | $2,477M | $3,065M | $2,479M |
| Free Cash Flow | $2,719M | -$151M | -$1,447M |
Per the filing: "Cash provided by operating activities from continuing operations in 2025 was primarily driven by the Company's cash earnings, advance payments received from customers related to long-term supply contracts and dividends from equity method investments, which were partially offset by cash used for working capital, performance-based compensation, pension contributions and severance payments."
FCF is negative for the second consecutive year. Operating cash flow collapsed from $5.2B to $1.0B over two years — a 80% decline. Meanwhile, CapEx remained high at $2.5B, driven by planned capital projects.
The Diamond Infrastructure Solutions transaction — where InfraPark purchased 49% of membership interests — "generated $2.5 billion of proceeds" which helped offset the cash flow deterioration.
The 18-Point Screening
Revenue Quality
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | ✅ | DSO 43 days, +3 days YoY |
| A2 | AR vs Revenue Growth | ❌ | AR outpaced revenue for 2 consecutive years |
| A3 | Revenue vs CFFO | ✅ | Revenue -7.0%, CFFO -64.6% |
Expense Quality
| # | Check | Result | Detail |
|---|---|---|---|
| B1 | Inventory vs COGS | ✅ | Inventory +0.8% vs COGS -2.4% |
| B2 | CapEx vs Revenue | ✅ | CapEx -19.1% vs revenue -7.0% |
| B3 | SG&A Ratio | ✅ | SG&A/Gross Profit = 55.0% |
| B4 | Gross Margin | ✅ | 6.3%, -4.4pp (technically "stable" per engine) |
Cash Flow Quality
| # | Check | Result | Detail |
|---|---|---|---|
| C1 | CFFO vs Net Income | ⚠️ | CFFO/NI = -0.39 (net loss year) |
| C2 | Free Cash Flow | ⚠️ | FCF is negative (-$1.4B) |
| C3 | Accruals Ratio | ✅ | -6.2%. Low accruals |
| C4 | Cash vs Debt | ❌ | Cash $3.8B covers only 19% of debt $19.6B |
C4 — Massive debt against depleted cash flow. Total debt grew from $17.6B to $19.6B while CFFO collapsed to $1.0B. Interest expense alone is $865M — consuming 84% of operating cash flow. This is unsustainable without a commodity price recovery.
Balance Sheet
| # | Check | Result | Detail |
|---|---|---|---|
| D1 | Goodwill + Intangibles | ❌ | $9.5B = 59% of equity |
| D2 | Leverage | ❌ | Debt/EBITDA = 16.5x, interest coverage 0.2x |
| D3 | Soft Asset Growth | ✅ | Other assets +6.3% vs revenue -7.0% |
| D4 | Asset Impairment | ✅ | Write-offs recorded (impairments) |
D2 — Critical leverage failure. Debt/EBITDA of 16.5x and interest coverage of 0.2x are crisis-level metrics. EBITDA collapsed due to the $993M in impairment charges and the commodity downturn. Even excluding impairments, leverage would be elevated. The filing warns its indebtedness could result in "our credit ratings being downgraded."
Acquisition Risk
| # | Check | Result | Detail |
|---|---|---|---|
| E1 | Serial Acquirer FCF | ⚠️ | FCF after acquisitions negative 2/3 years |
| E2 | Goodwill Surge | ✅ | Goodwill change -8% YoY (post-impairment) |
Manipulation Score
| # | Check | Result | Detail |
|---|---|---|---|
| F1 | Beneish M-Score | ✅ | -2.41 (passes) |
The GMI (Gross Margin Index) component at 1.692 is the highest across all M-Score components, reflecting the severe gross margin deterioration. This is not manipulation — it is a cyclical commodity collapse.
Key Risks from the 10-K
1. $993 Million in Impairment Charges
The $690M goodwill impairment at Polyurethanes & Construction Chemicals and $303M asset impairment in Latin America signal that management's own assessment is that these businesses are worth less than their carrying values. The filing's goodwill testing "determined the fair value of the Polyurethanes & Construction Chemicals reporting unit was lower than its carrying amount."
2. Union Carbide Asbestos Legacy
Dow's wholly-owned subsidiary Union Carbide carries asbestos-related liabilities. The filing references ongoing litigation that has persisted for decades. While largely reserved, any adverse legal developments could create additional charges.
3. 2025 Restructuring Program
"On January 27, 2025, the Board approved targeted actions to further achieve the Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty." Expected restructuring costs are approximately $260 million. The program reflects management's acknowledgment that the current cost structure is unsustainable at current commodity prices.
4. Environmental Remediation
Dow faces environmental liabilities at Superfund sites and other locations. The filing lists extensive environmental remediation obligations. As a legacy chemicals company, these liabilities represent an ongoing cash drain.
Summary
Grade: F. A cyclical commodity chemical company in the trough of its cycle, with collapsing margins, negative FCF, crisis-level leverage, and nearly $1 billion in impairment charges.
Dow's FY2025 results are catastrophic by almost any measure: revenue down 30% from peak, gross margin at 6.3%, net loss of $2.6B, negative FCF of $1.4B, Debt/EBITDA of 16.5x, and $993M in impairments. Four failed checks and three watch items produce the worst screening result in this batch. The M-Score passes at -2.41 because this is not manipulation — it is genuine cyclical distress in commodity chemicals. The 2025 Restructuring Program and the Diamond Infrastructure Solutions partial sale show management is taking action, but the fundamental problem is commodity pricing that Dow cannot control. A recovery in polyethylene, polyurethane, and silicone prices would rapidly improve the picture, but that recovery is not yet visible in the numbers.
**Disclaimer**: This report is based on Dow Inc.'s FY2025 10-K filed with SEC EDGAR on February 3, 2026. This is NOT investment advice.
Data: SEC EDGAR 10-K + Yahoo Finance
Auditor: Deloitte & Touche LLP (Unqualified opinion)
Fiscal year ended: December 31, 2025